Dengue virus (DENV), a mosquito-borne flavivirus, causes dengue fever, a significant global health concern prevalent in tropical and subtropical regions. Early and accurate diagnosis is critical for patient management and epidemiological control. The Dengue Virus ELISA kit is a crucial immunoassay tool designed for the detection and quantification of dengue virus antigens or antibodies (IgM, IgG) in human biological samples such as serum and plasma.
Principle and Assay Design
The Dengue Virus ELISA kit typically utilizes an indirect or sandwich immunoassay format. Microplates are coated with Dengue virus-specific antigens or antibodies (e.g., NS1 protein), which capture target antibodies or antigens from specimens. After incubation, an enzyme-conjugated secondary antibody binds the complex. Upon addition of a chromogenic substrate (usually TMB), a colorimetric reaction occurs, with intensity proportional to the analyte concentration, quantified by absorbance at 450 nm.
Sample Types
- Serum
- Plasma (citrate or heparin anticoagulated)
- Occasionally cell culture supernatants
Applications
- Clinical diagnosis: Enables detection of acute infection (NS1, IgM) or past exposure (IgG).
- Epidemiology: Seroprevalence studies and monitoring immunity status.
- Vaccine research: Evaluation of immunogenic response post-vaccination.
- Differentiation between primary and secondary infections: Certain kits differentiate based on distinct antibody profiles.
Advantages and Performance
- High sensitivity and specificity for Dengue virus detection, with validated reproducibility (intra- and inter-assay variation typically <15%).
- Rapid turnaround (2-5 hours), suited for routine diagnostic and research laboratory workflows.
- Safe, non-culture based assay minimizing biohazard exposure.
- Quantitative to semiquantitative results allow monitoring of antibody titers and kinetics.
In summary, the Dengue Virus ELISA kit is an essential tool for dengue infection diagnosis, surveillance, and research, offering sensitive, specific, and user-friendly immunoassay protocols adapted to various clinical and epidemiological needs.
